336 related articles for article (PubMed ID: 8910675)
1. Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death.
Reed JC; Zha H; Aime-Sempe C; Takayama S; Wang HG
Adv Exp Med Biol; 1996; 406():99-112. PubMed ID: 8910675
[TBL] [Abstract][Full Text] [Related]
2. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2.
Zha H; Aimé-Sempé C; Sato T; Reed JC
J Biol Chem; 1996 Mar; 271(13):7440-4. PubMed ID: 8631771
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the anti-apoptotic mechanism of Bcl-B.
Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC
Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534
[TBL] [Abstract][Full Text] [Related]
4. Bax homodimerization is not required for Bax to accelerate chemotherapy-induced cell death.
Simonian PL; Grillot DA; Andrews DW; Leber B; Nuñez G
J Biol Chem; 1996 Dec; 271(50):32073-7. PubMed ID: 8943258
[TBL] [Abstract][Full Text] [Related]
5. Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL.
Simonian PL; Grillot DA; Merino R; Nuñez G
J Biol Chem; 1996 Sep; 271(37):22764-72. PubMed ID: 8798452
[TBL] [Abstract][Full Text] [Related]
6. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4.
Huang DC; Adams JM; Cory S
EMBO J; 1998 Feb; 17(4):1029-39. PubMed ID: 9463381
[TBL] [Abstract][Full Text] [Related]
7. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.
Yin XM; Oltvai ZN; Korsmeyer SJ
Nature; 1994 May; 369(6478):321-3. PubMed ID: 8183370
[TBL] [Abstract][Full Text] [Related]
8. Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death.
Shangary S; Johnson DE
Biochemistry; 2002 Jul; 41(30):9485-95. PubMed ID: 12135371
[TBL] [Abstract][Full Text] [Related]
9. Heterodimerization-independent functions of cell death regulatory proteins Bax and Bcl-2 in yeast and mammalian cells.
Zha H; Reed JC
J Biol Chem; 1997 Dec; 272(50):31482-8. PubMed ID: 9395483
[TBL] [Abstract][Full Text] [Related]
10. Structure-function analysis of Bcl-2 protein. Identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax.
Hanada M; Aimé-Sempé C; Sato T; Reed JC
J Biol Chem; 1995 May; 270(20):11962-9. PubMed ID: 7744846
[TBL] [Abstract][Full Text] [Related]
11. BID: a novel BH3 domain-only death agonist.
Wang K; Yin XM; Chao DT; Milliman CL; Korsmeyer SJ
Genes Dev; 1996 Nov; 10(22):2859-69. PubMed ID: 8918887
[TBL] [Abstract][Full Text] [Related]
12. Functional identification of the apoptosis effector BH3 domain in cellular protein BNIP1.
Yasuda M; Chinnadurai G
Oncogene; 2000 May; 19(19):2363-7. PubMed ID: 10822388
[TBL] [Abstract][Full Text] [Related]
13. The BH3 domain of Bax is sufficient for interaction of Bax with itself and with other family members and it is required for induction of apoptosis.
Simonen M; Keller H; Heim J
Eur J Biochem; 1997 Oct; 249(1):85-91. PubMed ID: 9363757
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional complementation of an inactive Bcl-2 mutant by Bax truncation.
Ottilie S; Diaz JL; Chang J; Wilson G; Tuffo KM; Weeks S; McConnell M; Wang Y; Oltersdorf T; Fritz LC
J Biol Chem; 1997 Jul; 272(27):16955-61. PubMed ID: 9202007
[TBL] [Abstract][Full Text] [Related]
15. Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms.
Minn AJ; Kettlun CS; Liang H; Kelekar A; Vander Heiden MG; Chang BS; Fesik SW; Fill M; Thompson CB
EMBO J; 1999 Feb; 18(3):632-43. PubMed ID: 9927423
[TBL] [Abstract][Full Text] [Related]
16. Structural biology of the Bcl-2 family of proteins.
Petros AM; Olejniczak ET; Fesik SW
Biochim Biophys Acta; 2004 Mar; 1644(2-3):83-94. PubMed ID: 14996493
[TBL] [Abstract][Full Text] [Related]
17. harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L).
Inohara N; Ding L; Chen S; Núñez G
EMBO J; 1997 Apr; 16(7):1686-94. PubMed ID: 9130713
[TBL] [Abstract][Full Text] [Related]
18. Distinct domains of Bcl-XL are involved in Bax and Bad antagonism and in apoptosis inhibition.
Zhou H; Hou Q; Chai Y; Hsu YT
Exp Cell Res; 2005 Oct; 309(2):316-28. PubMed ID: 16061221
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 and Bax interact via the BH1-3 groove-BH3 motif interface and a novel interface involving the BH4 motif.
Ding J; Zhang Z; Roberts GJ; Falcone M; Miao Y; Shao Y; Zhang XC; Andrews DW; Lin J
J Biol Chem; 2010 Sep; 285(37):28749-63. PubMed ID: 20584903
[TBL] [Abstract][Full Text] [Related]
20. Interaction of E1B 19K with Bax is required to block Bax-induced loss of mitochondrial membrane potential and apoptosis.
Han J; Modha D; White E
Oncogene; 1998 Dec; 17(23):2993-3005. PubMed ID: 9881701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
